---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-033266"
form_type: "8-K"
ticker: null
cik: "0001819113"
company_name: "Science 37 Holdings, Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:14:24.022042+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Science 37 acquired by eMed in $38M all-cash deal; shares to be delisted from Nasdaq

## Summary
- eMed's Merger Sub completed tender offer at $5.75/share; 77.8% of shares tendered.
- Merger closed March 12, 2024; remaining shares converted to $5.75 per share cash.
- Aggregate consideration of ~$38M, funded from eMed's cash and short-term borrowing.
- All 7 directors resigned; Michael Cole and Jeffrey Schumm appointed as new board.
- Science 37 requested Nasdaq delisting and will file Form 15 to suspend SEC reporting.

## SEC filing metadata
- accession: 0001104659-24-033266
- form_type: 8-K
- cik: 0001819113
- company_name: Science 37 Holdings, Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 2.01, 3.01, 3.03, 5.01, 5.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/tm244329d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-033266
- JSON: https://secwatch.observer/filing/0001104659-24-033266.json
- Plain text: https://secwatch.observer/filing/0001104659-24-033266.txt

## Key facts
- Executive change
  David Coman resigned as director at Science 37 Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  Bhooshitha B. De Silva resigned as director at Science 37 Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  Jeffrey Schumm was appointed as director at Science 37 Holdings, Inc..
  - Action: became
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  Neil Tiwari resigned as director at Science 37 Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  John W. Hubbard resigned as director at Science 37 Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  Emily Rollins resigned as director at Science 37 Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  Paul von Autenried resigned as director at Science 37 Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  Michael Cole was appointed as director at Science 37 Holdings, Inc..
  - Action: became
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Executive change
  Robert Faulkner resigned as director at Science 37 Holdings, Inc..
  - Action: resigned
  - Role: director
  source text: Pursuant to the terms of the Merger Agreement, and effective as of the Effective Time, each director of the Company immediately prior to the Effective Time, David Coman, Robert Faulkner, Bhooshitha B. De Silva, John W. Hubbard, Emily Rollins, Neil Tiwari and Paul von Autenried, resigned as a director of the Company and Michael Cole and Jeffrey Schumm became the directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Governance Changes
  Science 37 Holdings, Inc.: Amended and restated bylaws in their entirety.
  - Change: bylaw amendment
  source text: the Company’s bylaws, as in effect immediately prior to the Effective Time, were amended and restated in their entirety (the “ Second Amended and Restated Bylaws ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- Governance Changes
  Science 37 Holdings, Inc.: Amended and restated certificate of incorporation in its entirety.
  - Change: charter amendment
  source text: the Company’s certificate of incorporation, as in effect immediately prior to the Effective Time, was amended and restated in its entirety (the “ Third Amended and Restated Certificate of Incorporation ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
- M&A Transactions
  Science 37 Holdings, Inc. underwent a change of control involving eMed, LLC for $5.75 per Share (closed 2024-03-12).
  - Action: change of control
  - Counterparty: eMed, LLC
  - Consideration: $5.75 per Share
  - Closing: 2024-03-12
  source text: 2024, Merger Sub commenced a cash tender offer for all of the Company’s outstanding shares of common stock, par value $0.0001 per share (“ Shares ”), at a purchase price of $5.75 per Share (the “ Offer Price ” ), net to the seller in cash, without interest, subject to any required withholding of taxes, upon the terms and subject to the conditions set forth
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.